Srinivasan Krishnamachari, Thomas Tinku, Kapanee Aruna Rose Mary, Ramthal Asha, Bellinger David C, Bosch Ronald J, Kurpad Anura V, Duggan Christopher
Division of Mental Health and Neurosciences, St. John's Research Institute, Bengaluru, Karnataka, India.
Department of Psychiatry, St. John's Medical College, Bangalore, Karnataka, India.
Matern Child Nutr. 2017 Apr;13(2). doi: 10.1111/mcn.12325. Epub 2016 Jun 29.
Maternal nutritional status during pregnancy impacts fetal brain development. Vitamin B12 plays a vital role in neuronal development. However, findings from studies on the association between maternal B12 status and child cognitive functions have been inconsistent. We performed a randomized, placebo-controlled clinical trial of oral B12 supplementation (50 µg) beginning at <14 weeks of gestation through a 6-week post-partum. In the present study, we report the effects of maternal B12 supplementation on cognitive development in infants at 9 months of age on Bayley Scales of Infant Development-III (BSID-III). One hundred eighty-three pregnant women received vitamin B12, and 183 received placebo. Nine-month BSID-III development score was available in 178 infants. There were no significant differences in maternal sociodemographic characteristics and baseline biochemical measures between infants who underwent BSID-III evaluation and infants who were not evaluated. There were no significant differences in any of the subscales of BSID-III between infants born to mothers who received B12 supplementation (n = 78) vs. placebo (n = 100). On multiple regression analysis, elevated maternal total homocysteine (tHcy) levels adjusted for treatment group, birthweight, parity, income and home environment at second trimester of pregnancy were significantly negatively associated with expressive language (β = 3.13 points, P < 0.001), and in third trimester of pregnancy with expressive language (β = -2.29 points, P < 0.001) and fine motor (β = -1.41 points, P = 0.005) domains of BSID-III. While no significant effects of maternal B12 supplementation were seen on cognitive development in infants at 9 months of age, elevated maternal tHcy levels were associated with poorer cognitive performance in some of the subdomains of BSID-III. In pregnant women with elevated tHcy levels and or B12 deficiencies, it may be worthwhile to study the impact of longer term maternal supplementation on infant cognitive outcomes.
孕期母亲的营养状况会影响胎儿大脑发育。维生素B12在神经元发育中起着至关重要的作用。然而,关于母亲维生素B12状况与儿童认知功能之间关联的研究结果并不一致。我们进行了一项随机、安慰剂对照的临床试验,从妊娠<14周开始口服补充维生素B12(50μg),持续至产后6周。在本研究中,我们报告了母亲补充维生素B12对9个月大婴儿在贝利婴幼儿发展量表第三版(BSID-III)上认知发展的影响。183名孕妇接受了维生素B12,183名孕妇接受了安慰剂。178名婴儿有9个月时的BSID-III发育评分。接受BSID-III评估的婴儿与未接受评估的婴儿在母亲社会人口学特征和基线生化指标方面无显著差异。接受维生素B12补充的母亲所生婴儿(n = 78)与接受安慰剂的母亲所生婴儿(n = 100)在BSID-III的任何子量表上均无显著差异。在多元回归分析中,根据治疗组、出生体重、产次、收入和妊娠中期的家庭环境进行调整后,母亲总同型半胱氨酸(tHcy)水平升高与表达性语言显著负相关(β = 3.13分,P < 0.001),在妊娠晚期与表达性语言(β = -2.29分,P < 0.001)和BSID-III的精细运动(β = -1.41分,P = 0.005)领域显著负相关。虽然未观察到母亲补充维生素B12对9个月大婴儿认知发展有显著影响,但母亲tHcy水平升高与BSID-III某些子领域的较差认知表现相关。在tHcy水平升高和/或维生素B12缺乏的孕妇中,研究母亲长期补充对婴儿认知结局的影响可能是值得的。